Literature DB >> 7548609

Permeability and blood compatibility properties of chitosan-poly(ethylene oxide) blend membranes for haemodialysis.

M M Amiji1.   

Abstract

Chitosan-poly(ethylene oxide) (PEO) blend membranes, using different molecular weights of PEO, were developed for improved permeability and blood compatibility. The equilibrium hydration increased from 44.7% for chitosan to 62.5% for chitosan-PEO blend membranes when the molecular weight of PEO was 10,000 (10K) or higher. An increase in the hydration of PEO blend membranes was due to intermolecular association between PEO and chitosan chains. Scanning electron microscopy showed that chitosan-PEO membranes were highly porous with size ranging from 50 to 80 nm in diameter observed in membranes made with PEO10K. Electron spectroscopy for chemical analysis suggested an increase in PEO on the membrane surface with increasing molecular weight in the blend. The permeability coefficient of urea increased from 5.47 x 10(-5) cm2 min-1 in chitosan to 9.86 x 10(-5) cm2 min-1 in chitosan-PEO10K membranes. The increase in permeability coefficient could be either due to an increase in the hydrophilicity or the high porosity of the membranes. Although chitosan-PEO membranes did not prevent serum complement activation, platelet adhesion and activation were significantly reduced. Chitosan-PEO blend membranes, therefore, appear to be beneficial in improving the permeability of toxic metabolites and in reducing the thrombogenicity for haemodialysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548609     DOI: 10.1016/0142-9612(95)93856-9

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Preparation and characterization of chitosan hybrid membranes containing polyethylacrylate and polybutylacrylate.

Authors:  F A Abdel-Mohdy; S M El-Sawy; A Abou-Okeil
Journal:  J Membr Biol       Date:  2011-11-09       Impact factor: 1.843

2.  Recyclable heparin and chitosan conjugated magnetic nanocomposites for selective removal of low-density lipoprotein from plasma.

Authors:  Jinghua Li; Yanhua Hou; Xiuyong Chen; Xingwei Ding; Yun Liu; Xinkun Shen; Kaiyong Cai
Journal:  J Mater Sci Mater Med       Date:  2014-01-07       Impact factor: 3.896

3.  Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

Authors:  S M Sivakumar; Mohammed M Safhi; M Kannadasan; N Sukumaran
Journal:  Saudi Pharm J       Date:  2011-06-25       Impact factor: 4.330

4.  Surface properties and in vitro analyses of immobilized chitosan onto polypropylene non-woven fabric surface using antenna-coupling microwave plasma.

Authors:  Yu-Chang Tyan; Jiunn-Der Liao; Shu-Ping Lin
Journal:  J Mater Sci Mater Med       Date:  2003-09       Impact factor: 3.896

5.  Preparation and characterization of pH sensitive sugar mediated (polyethylene glycol/chitosan) membrane.

Authors:  Jian Wen Wang; Min Hsiung Hon
Journal:  J Mater Sci Mater Med       Date:  2003-12       Impact factor: 3.896

6.  Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.

Authors:  Maitiseyiti Abulaihaiti; Xiang-Wei Wu; Lei Qiao; Hai-Long Lv; Hong-Wei Zhang; Nasrul Aduwayi; Yan-Jie Wang; Xin-Chun Wang; Xin-Yu Peng
Journal:  PLoS Negl Trop Dis       Date:  2015-09-09

7.  Electrospun Chitosan Functionalized with C12, C14 or C16 Tails for Blood-Contacting Medical Devices.

Authors:  Monica Dettin; Martina Roso; Grazia M L Messina; Giovanna Iucci; Valentina Peluso; Teresa Russo; Annj Zamuner; Marta Santi; Sabrina Milan Manani; Monica Zanella; Chiara Battocchio; Giovanni Marletta; Michele Modesti; Mario Rassu; Massimo De Cal; Claudio Ronco
Journal:  Gels       Date:  2022-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.